211 related articles for article (PubMed ID: 2449462)
1. Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release.
Schulman ES; Post TJ; Henson PM; Giclas PC
J Clin Invest; 1988 Mar; 81(3):918-23. PubMed ID: 2449462
[TBL] [Abstract][Full Text] [Related]
2. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.
el-Lati SG; Dahinden CA; Church MK
J Invest Dermatol; 1994 May; 102(5):803-6. PubMed ID: 7513741
[TBL] [Abstract][Full Text] [Related]
3. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion.
Marone G; Cirillo R; Genovese A; Marino O; Quattrin S
Life Sci; 1989; 45(19):1745-54. PubMed ID: 2480501
[TBL] [Abstract][Full Text] [Related]
4. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
5. Differential release of mediators from human basophils: differences in arachidonic acid metabolism following activation by unrelated stimuli.
Warner JA; Peters SP; Lichtenstein LM; Hubbard W; Yancey KB; Stevenson HC; Miller PJ; MacGlashan DW
J Leukoc Biol; 1989 Jun; 45(6):558-71. PubMed ID: 2470847
[TBL] [Abstract][Full Text] [Related]
6. Human C5a induces a substantial histamine release in human basophils but not in tissue mast cells.
Jürgensen H; Braam U; Pult P; Kownatzki E; Schmutzler W
Int Arch Allergy Appl Immunol; 1988; 85(4):487-8. PubMed ID: 2451646
[TBL] [Abstract][Full Text] [Related]
7. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
8. General anaesthetics induce only histamine release selectively from human mast cells.
Stellato C; Casolaro V; Ciccarelli A; Mastronardi P; Mazzarella B; Marone G
Br J Anaesth; 1991 Dec; 67(6):751-8. PubMed ID: 1722691
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 3-dependent mediator release in basophils triggered by C5a.
Kurimoto Y; de Weck AL; Dahinden CA
J Exp Med; 1989 Aug; 170(2):467-79. PubMed ID: 2474054
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory properties of human C5a and C5a des Arg/ in mast cell-depleted human skin.
Swerlick RA; Yancey KB; Lawley TJ
J Invest Dermatol; 1989 Sep; 93(3):417-22. PubMed ID: 2527912
[TBL] [Abstract][Full Text] [Related]
11. The effects of the anaphylatoxins C3a and C5a on isolated mast cells from rat and man.
Jürgensen H; Behrendt H; Damerau B; Schmutzler W
Agents Actions; 1986 Apr; 18(1-2):153-4. PubMed ID: 2425572
[TBL] [Abstract][Full Text] [Related]
12. Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue.
Genovese A; Stellato C; Patella V; Lamparter-Schummert B; de Crescenzo G; Adt M; Marone G
Int J Clin Lab Res; 1996; 26(3):192-8. PubMed ID: 8905451
[TBL] [Abstract][Full Text] [Related]
13. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin.
Marone G; Columbo M; Galeone D; Guidi G; Kagey-Sobotka A; Lichtenstein LM
Agents Actions; 1986 Apr; 18(1-2):100-2. PubMed ID: 2425566
[TBL] [Abstract][Full Text] [Related]
15. The degradation product of the C5a anaphylatoxin C5adesarg retains basophil-activating properties.
Bürgi B; Brunner T; Dahinden CA
Eur J Immunol; 1994 Jul; 24(7):1583-9. PubMed ID: 7517876
[TBL] [Abstract][Full Text] [Related]
16. Physiological concentrations of zinc inhibit the release of histamine from human basophils and lung mast cells.
Marone G; Columbo M; de Paulis A; Cirillo R; Giugliano R; Condorelli M
Agents Actions; 1986 Apr; 18(1-2):103-6. PubMed ID: 2425567
[TBL] [Abstract][Full Text] [Related]
17. The pharmacologic control of mediator release from human basophils and mast cells.
Peters SP; Naclerio RM; Schleimer RP; MacGlashan DW; Pipkorn U; Lichtenstein LM
Respiration; 1986; 50 Suppl 2():116-22. PubMed ID: 3494282
[TBL] [Abstract][Full Text] [Related]
18. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
Undem BJ; Peachell PT; Lichtenstein LM
J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity.
Lawrence ID; Warner JA; Cohan VL; Hubbard WC; Kagey-Sobotka A; Lichtenstein LM
J Immunol; 1987 Nov; 139(9):3062-9. PubMed ID: 2444649
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of histamine, leukotriene C4/D4, and thromboxane B2 release from human leukocytes and human chopped lung mast cells by the allergic mediator release inhibitor, CI-949.
Conroy MC; Kennedy JA; Chestnut JC; Wright CD; Adolphson RL; Thueson DO
J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 1):902-8. PubMed ID: 1702129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
